
Sign up to save your podcasts
Or
Today we'll be discussing the ALMS trial, which pitted cellcept against cyclophosphamide. It's a good trial that has had profound influences on our practice and well worth a read. Access the paper itself here.
4.9
111111 ratings
Today we'll be discussing the ALMS trial, which pitted cellcept against cyclophosphamide. It's a good trial that has had profound influences on our practice and well worth a read. Access the paper itself here.
315 Listeners
498 Listeners
124 Listeners
3,331 Listeners
1,107 Listeners
119 Listeners
197 Listeners
517 Listeners
350 Listeners
168 Listeners
70 Listeners
4 Listeners
174 Listeners
6 Listeners
19 Listeners